Analyst Ranking
Top 33%
#1816 out of 5550 analysts
Average Return
+1.9%
Win Rate
55%18 out of 33
Risk vs Reward
Poor
Good

Michael Ryskin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Singular Genomics Systems IncOMIC
+79.62%$103.20$21.03
2022-08-10 -
2023-08-09
Sell
Absci CorpABSI
+75.41%$12.89$3.17
2021-11-10 -
2022-11-09
Sell
Revvity IncRVTY
+66.44%$86.27$143.59
2025-09-22 -
2026-09-21
Strong Buy
Guardant Health IncGH
+51.78%$31.15$47.28
2024-07-18 -
2025-07-17
Strong Buy
Schrodinger IncSDGR
+49.04%$18.21$27.14
2025-12-15 -
2026-10-30
Strong Buy

Michael Ryskin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Agilent Technologies IncA
1Strong Buy$180.00+2.93%Maintains
2 months ago
Labcorp Holdings IncLH
1Strong Buy$320.00-11.45%Maintains
4 months ago
Guardant Health IncGH
2Strong Buy$190.00+6.26%Maintains
4 months ago
Icon PLCICLR
2Sell$150.00-29.03%Maintains
4 months ago
Recursion Pharmaceuticals IncRXRX
2Hold$6.00+48.88%Maintains
8 months ago
Zoetis IncZTS
7Hold$140.00+75.61%Maintains
9 months ago
Schrodinger IncSDGR
3Strong Buy$24.00-11.57%Upgrades
a year ago
Revvity IncRVTY
1Strong Buy$99.00N/AMaintains
a year ago
Tempus Ai IncTEM
6Hold$70.00N/AMaintains
a year ago
Idexx Laboratories IncIDXX
3Hold$475.00N/AMaintains
2 years ago
Maravai Lifesciences Holdings IncMRVI
3Strong Buy$8.00N/AMaintains
2 years ago
Align Technology IncALGN
6Sell$206.00N/AMaintains
2 years ago
Alight IncALIT
1Strong Buy$190.00N/AMaintains
2 years ago
Exscientia PLCEXAI
2Hold$9.00N/ADowngrades
3 years ago
Certara IncCERT
2Strong Buy$24.00N/AMaintains
3 years ago
Avantor IncAVTR
2Strong Buy$24.00N/AMaintains
3 years ago
Abcam PLCABCM
2Strong Buy$25.00N/AUpgrades
3 years ago
Singular Genomics Systems IncOMIC
3Sell$90.00N/ADowngrades
4 years ago
Absci CorpABSI
2Sell$10.00N/ADowngrades
5 years ago
Smiledirectclub IncSDCCQ
1Sell$7.00N/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.